Featured Insights
-
Vigilance Guidance Provides Greater Clarity On MDR Requirements
6/12/2024
Explore how new vigilance guidance under MDR clarifies reporting obligations for high-risk medical devices, ensuring enhanced safety oversight and compliance amid stricter regulations.
-
How Intuitive Decision Rules In Clinical Trials Can Support Regulatory Requirements
6/12/2024
See how Bayesian decision rules in clinical trials can align with regulatory standards, offering intuitive and adaptive solutions amidst traditional challenges in frequentist frameworks.
-
EMA's Concept Paper On Confirmatory Clinical Studies A Welcome Step For Industry
6/12/2024
Explore the implications of the European Medicines Agency's Concept Paper, its potential impact on biosimilar developers, and the broader implications for the pharmaceutical industry.
-
Navigating Promotional Materials Requirements In Europe
6/12/2024
From navigating local laws to strategic planning, explore how companies can manage their promotional campaigns while adhering to strict regulatory guidelines.
-
Opportunities And Risks As Biosimilars Come Of Age
6/12/2024
As biosimilars mature, they promise expanded patient access and healthcare savings. Despite regulatory hurdles, collaboration and innovation will drive their future growth and impact.
-
How AI Can Support The Trial Master File
6/12/2024
As industries embrace AI's potential, its application in Trial Master File (TMF) processes shows promise for efficiency gains and improved quality control in clinical trials.
-
Why Access Consortium Makes Sense For Industry And Regulators
5/22/2024
The Access Consortium has significantly advanced regulatory convergence, creating synergies and sharing knowledge among its members. Here’s why it is beneficial for both industry and regulators alike.
-
Realizing Business Benefit And Inspection Readiness With A Solid CAPA Framework
5/8/2024
Embracing proactive quality culture transforms CAPA from a routine task to a continuous improvement tool. Learn how senior management support and robust processes drive excellence.
-
Getting The CAPA Framework Right The First Time
5/8/2024
CAPA processes, though often seen as regulatory burdens, offer significant business benefits. Implementing them requires a cultural shift and methodical approach for lasting improvement.